These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 23185502)

  • 21. Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression.
    Ware KE; Marshall ME; Heasley LR; Marek L; Hinz TK; Hercule P; Helfrich BA; Doebele RC; Heasley LE
    PLoS One; 2010 Nov; 5(11):e14117. PubMed ID: 21152424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer.
    Saridogan T; Akcakanat A; Zhao M; Evans KW; Yuca E; Scott S; Kirby BP; Zheng X; Ha MJ; Chen H; Ng PKS; DiPeri TP; Mills GB; Rodon Ahnert J; Damodaran S; Meric-Bernstam F
    Sci Rep; 2023 Nov; 13(1):20223. PubMed ID: 37980453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Analysis of Fibroblast Growth Factor Receptor (FGFR) Family Genes in Breast Cancer by Integrating Online Databases and Bioinformatics.
    Zhou Z; Wu B; Tang X; Ke R; Zou Q
    Med Sci Monit; 2020 May; 26():e923517. PubMed ID: 32381997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring mechanisms of FGF signalling through the lens of structural biology.
    Goetz R; Mohammadi M
    Nat Rev Mol Cell Biol; 2013 Mar; 14(3):166-80. PubMed ID: 23403721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients.
    Erber R; Rübner M; Davenport S; Hauke S; Beckmann MW; Hartmann A; Häberle L; Gass P; Press MF; Fasching PA
    Breast Cancer Res Treat; 2020 Nov; 184(2):311-324. PubMed ID: 32852708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.
    Hu Y; Guimond SE; Travers P; Cadman S; Hohenester E; Turnbull JE; Kim SH; Bouloux PM
    J Biol Chem; 2009 Oct; 284(43):29905-20. PubMed ID: 19696444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alofanib, an allosteric FGFR2 inhibitor, has potent effects on ovarian cancer growth in preclinical studies.
    Tyulyandina A; Harrison D; Yin W; Stepanova E; Kochenkov D; Solomko E; Peretolchina N; Daeyaert F; Joos JB; Van Aken K; Byakhov M; Gavrilova E; Tjulandin S; Tsimafeyeu I
    Invest New Drugs; 2017 Apr; 35(2):127-133. PubMed ID: 27812884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance.
    Chell V; Balmanno K; Little AS; Wilson M; Andrews S; Blockley L; Hampson M; Gavine PR; Cook SJ
    Oncogene; 2013 Jun; 32(25):3059-70. PubMed ID: 22869148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential distribution of fibroblast growth factor receptors (FGFRs) on foveal cones: FGFR-4 is an early marker of cone photoreceptors.
    Cornish EE; Natoli RC; Hendrickson A; Provis JM
    Mol Vis; 2004 Jan; 10():1-14. PubMed ID: 14737068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
    Hibi M; Kaneda H; Tanizaki J; Sakai K; Togashi Y; Terashima M; De Velasco MA; Fujita Y; Banno E; Nakamura Y; Takeda M; Ito A; Mitsudomi T; Nakagawa K; Okamoto I; Nishio K
    Cancer Sci; 2016 Nov; 107(11):1667-1676. PubMed ID: 27581340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function.
    Pond AC; Bin X; Batts T; Roarty K; Hilsenbeck S; Rosen JM
    Stem Cells; 2013 Jan; 31(1):178-89. PubMed ID: 23097355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
    Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
    Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
    [No Abstract]   [Full Text] [Related]  

  • 33. Overexpression of fibroblast growth factor receptors FGFR1 and FGFR2 in renal cell carcinoma.
    Tsimafeyeu I; Demidov L; Stepanova E; Wynn N; Ta H
    Scand J Urol Nephrol; 2011 Apr; 45(3):190-5. PubMed ID: 21329481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. siRNA mediated knockdown of fibroblast growth factor receptors 1 or 3 inhibits FGF-induced anchorage-independent clonogenicity but does not affect MAPK activation.
    Estes NR; Thottassery JV; Kern FG
    Oncol Rep; 2006 Jun; 15(6):1407-16. PubMed ID: 16685373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells.
    Ruohola JK; Valve EM; Vainikka S; Alitalo K; Härkönen PL
    Endocrinology; 1995 May; 136(5):2179-88. PubMed ID: 7536664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER
    Mao P; Cohen O; Kowalski KJ; Kusiel JG; Buendia-Buendia JE; Cuoco MS; Exman P; Wander SA; Waks AG; Nayar U; Chung J; Freeman S; Rozenblatt-Rosen O; Miller VA; Piccioni F; Root DE; Regev A; Winer EP; Lin NU; Wagle N
    Clin Cancer Res; 2020 Nov; 26(22):5974-5989. PubMed ID: 32723837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
    Zhang L; Kharbanda S; Hanfelt J; Kern FG
    Cancer Res; 1998 Jan; 58(2):352-61. PubMed ID: 9443417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The roles of FGF signaling in germ cell migration in the mouse.
    Takeuchi Y; Molyneaux K; Runyan C; Schaible K; Wylie C
    Development; 2005 Dec; 132(24):5399-409. PubMed ID: 16291796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells.
    Chi F; Griffiths JI; Nath A; Bild AH
    Breast Cancer Res; 2024 Mar; 26(1):54. PubMed ID: 38553760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of fibroblast growth factor receptor 2 and 3 in the late stages of fetal lung development in the nitrofen rat model.
    Friedmacher F; Doi T; Gosemann JH; Fujiwara N; Kutasy B; Puri P
    Pediatr Surg Int; 2012 Feb; 28(2):195-9. PubMed ID: 21994076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.